Skip to main content

Table 1 Baseline demographic and clinic characteristics of 373 HIV-infected patients undergoing tuberculin skin test, QuantiFERON-TB Gold and T-SPOT-TB testing, stratified according to past or current tuberculosis (TB) and previous positive tuberculin skin test (TST)

From: Contribution of Interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: A comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test

 

All patients (n = 373)

Patients with past or current TB (n = 56)

Patients with positive TST treated (n = 15)

Patients with no past or current TB nor positive TST (n = 302)

P value*

Demography

     

Median age, years (range)

44 (15-85)

45 (21-74)

42 (27-50)

44 (15-85)

NS

Sex, male

287 (76.9)

44 (78.6)

14 (93.3)

229 (75.8)

NS

Origin from a country with high prevalence of TB

28 (7.5)

7 (12.5)

1 (6.7)

20 (6.7)

NS

HIV-related factors

     

Prior AIDS defining illness

144 (38.6)

50 (89.3)

4 (26.7)

92 (30.5)

<0.001

Median CD4 cell count, cells/μl (range)

470 (10-1760)

350

442 (120-1200)

500 (10-1760)

0.02

  

(10-1550)

   

CD4 cell count < 200/μl

62 (16.6)

20 (35.7)

3 (20)

39 (12.9)

<0.001

CD4 cell count < 350/μl

135 (36.2)

28 (50)

9 (60)

101 (33.4)

0.03

CD4 cell count < 500/μl

198 (53.1)

35 (62.5)

10 (66.7)

153 (50.7)

0.07

Median nadir CD4 cell count, cells/μl (range)

150 (5-1650)

70 (5-1220)

240 (42-500)

180 (5-1650)

<0.001

Median HIV-1 ARN viral load, copies/ml (range)

<50 (0-1 x 106)

115 (0-1 x 106)

<50 (0-85486)

<50 (0-1 x 106)

NS

HIV-1 RNA viral load < 50 copies/ml

218 (58.4)

35 (49.3)

11 (74)

183 (60.6)

NS

ART-naïve

95 (25.5)

24 (42.8)

13 (86.7)

77 (25.5)

NS

Median time (years) since 1st HIV-positive test (range)

10 (0-27)

12 (0.1-22)

12 (3-24)

10 (0.1-27)

0.001

BCG vaccine

58 (15.8)

13 (23.2)

5 (33.3)

40 (13.9)

0.02

Risk factors for TB infection

     

Contact with patients with TB

144 (38.7)

40 (71.4)

11 (17.3)

93 (30.9)

<0.001

History of injection drug use

187 (50.1)

35 (62.5)

14 (93.3)

138 (45.7)

0.001

History of prior prison stay

102 (27.3)

29 (51.8)

13 (86.7)

60 (19.9)

<0.001

Lived in a shelter or homeless

97 (26.0)

22 (39.2)

6 (40)

66 (21.9)

<0.001

Diabetes mellitus

16 (4.3)

1 (1.1)

1 (6.7)

14 (4.6)

NS

Others

     

Hepatitis C virus co-infection

167 (45.1)

33 (58.9)

14 (93.3)

120 (40.0)

<0.001

  1. NOTE. Data are no (%) of patients unless otherwise indicated; ART, antiretroviral therapy; BCG, Bacille Calmette-Guérin; * p-value compared the patients with past or current TB and previous positive TST with patients with no past or current TB nor positive TST.